Congress to Clinic: Myeloid Malignancies Clinical Advances Journal Club on Emerging MPN, MDS, and AML Data

Understand how new data from the 2024 ASCO Annual Meeting and EHA Congress on specific myeloid malignancies (AML, MPN, MDS) will impact your clinical practice, through a series of expert-written ClinicalThought commentaries and podcasts, as well as an on-demand webcast with accompanying slides.

Share

Program Content

Activities

AML
Emerging Data in AML
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2024

Expires: June 25, 2025

Emerging Data for AML
Congress to Clinic: Expert Takeaways on Emerging Data for AML
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2024

Expires: July 07, 2025

Activities

MPNs
Emerging Data in Myeloproliferative Neoplasms
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2024

Expires: June 24, 2025

Emerging Data for MPNs
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 12, 2024

Expires: July 11, 2025

Activities

MDS
Emerging Data in MDS
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2024

Expires: June 25, 2025

Emerging Data for MDS
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2024

Expires: July 07, 2025

Faculty

cover img faculity

Courtney DiNardo, MD, MSCE

Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
Houston, Texas

cover img faculity

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Bristol-Myers Squibb

Bristol Myers Squibb